[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯
概要:[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯(CAS 101021-02-7)是一种化学化合物,分子式为C47H76O17,分子量为912.51 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务,支持克级到吨级规格。
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-dihydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
又称:Guaiacin B, [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-dihydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate, Oleanolic acid-3-O-(glucopyranosyl-1-3-arabinopyranosyl)-28-1-glucopyranosyl ester, ((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl) (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-((2S,3R,4S,5S)-3,5-dihydroxy-4-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyoxan-2-yl)oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
| 分子式 | C47H76O17 |
|---|---|
| 分子量 | 912.51 g/mol |
| LogP | 2.6 |
| 拓扑极性表面积 | 275.0 Ų |
| 氢键供体数 | 10 |
| 氢键受体数 | 17 |
| 可旋转键数 | 9 |
| 精确质量 | 912.50824 |
| 重原子数 | 64 |
| 复杂度 | 1740.0 |
化学标识符
| CAS 编号 | 101021-02-7 |
|---|---|
| SMILES | C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@H](CO7)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O |
| InChIKey | LCMURMAVBYASPU-REEYWUBFSA-N |
📋 应用领域
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯主要应用于有机合成与工艺化学。在实验室中常作为通用有机合成砌块使用。科弘生物供应[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯(CAS 101021-02-7),提供毫克级到公斤级定制合成,随货提供COA、MSDS及HPLC/NMR/MS分析报告。
产品概述
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯(CAS 101021-02-7)是一种精细化学品,分子式为C47H76O17,分子量 912.51 g/mol。 该化合物又名Guaiacin B、[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-dihydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate。
科弘生物提供目录供应与定制合成(毫克至吨级),支持HPLC/NMR/MS全套检测,随货附COA与MSDS。请告知所需数量与纯度,获取报价与货期。
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯化学性质概览
属性洞察:[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的XLogP值为2.6,表明具有中等亲脂性,在水溶性和膜透过性之间取得平衡。 TPSA为275.0 Ų,极性较高,提示该化合物膜透过性可能受限但水溶性较好。 根据Lipinski五规则,[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯有10个氢键供体和17个氢键受体,可能需要考虑配方优化。
常见问题
常见问题
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的CAS号是多少?
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的CAS号为101021-02-7。
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的分子式是什么?
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的分子式为C47H76O17。
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的分子量是多少?
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的分子量为912.51 g/mol。
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯有哪些应用?
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]...
在哪里可以购买[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯?
您可以直接向科弘生物询价[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯的定制合成服务?
是的,科弘生物提供[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-3,5-二羟基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)噁烷-2-基]氧代氧杂-2-基]氧代-2,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢苦味烯-4a-羧酸酯及相关化合物的定制合成服务。请联系我们并告知您的具体需求,包括数量、纯度和交期。